| Authors: |
Adam A; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Besson D; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Bryant R; Brychem/Agranova, BR6 9AP Kent, United Kingdom., Rees S; Innovative Vector Control Consortium, L3 5QA Liverpool, United Kingdom., Willis PA; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Burrows JN; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Hooft van Huisjduijnen R; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Laleu B; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Norton L; Innovative Vector Control Consortium, L3 5QA Liverpool, United Kingdom., Canan S; Bristol Myers Squibb, California 92121, San Diego, United States of America., Hawryluk N; Bristol Myers Squibb, California 92121, San Diego, United States of America., Robinson D; Bristol Myers Squibb, California 92121, San Diego, United States of America., Palmer M; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland., Samby KK; MMV Medicines for Malaria Venture, 1215 Geneva, Switzerland. |